Pacific Biosciences Of California | PACB - Debt


Pacific Biosciences Of California reported $892.24M in Debt for its fiscal quarter ending in December of 2023.





Debt Change Date
Agilent USD 3.35B 0 Dec/2025
Bruker USD 2.04B 34.4M Dec/2025
Danaher USD 26.56B 8.07B Jun/2026
General Electric Aerospace USD 19.16B 1.12B Jun/2026
Illumina USD 2.54B 9M Mar/2026
Myriad Genetics USD 59.3M 19.7M Mar/2025
Pacific Biosciences Of California USD 892.24M 653K Dec/2023
Quidel USD 2.87B 40.8M Mar/2026
Revvity USD 3.4B 29.2M Dec/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Standard Biotools USD 29.49M 2.1M Mar/2026
Thermo Fisher Scientific USD 43.16B 3.78B Mar/2026
Waters USD 1.49B 4.92M Dec/2025